BATF3 and neoplasm: Versikine also enhances the generation of CD103+CD11c+MHCII+ cDCs from Flt3L-mobilized primary bone marrow-derived progenitors, suggesting that Versican proteolysis may promote differentiation of tumor-seeding DC precursors toward IRF8- and BATF3-expressing cDCs in a mouse model (67).